Abstract
3 Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections in Intravenous Drug Users: Results from SOLO Trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have